Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

19

Revenue 2017

Keytruda

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Keytruda was produced by Merck & Co..

Tecentriq combo shows promise in triple negative breast cancer

Tecentriq combo shows promise in triple negative breast cancer

Roche. Tecentriq's FDA approval in triple negative breast cancer will help it expand in a market dominated by Merck &Co's Keytruda. ... Keynote-552 is investigating Keytruda in combination with different chemotherapy regimens in the neoadjuvant setting

NICE green light for Imfinzi in groundbreaking early lung cancer treatment

NICE green light for Imfinzi in groundbreaking early lung cancer treatment The ruling is great news for the company, as it gives Imfinzi its best chance of competing in the NSCLC market, where MSD’s Keytruda has become the overwhelmingly dominant player. ... Keytruda has marketing authorisation around the world as a

CHMP recommends new Keytruda dosing schedule

CHMP recommends new Keytruda dosing schedule 1 inhibitor that brought in a respectable $6.7bn year, but trailed behind Keytruda and its full year earnings of $7.2bn. ... The PD-1/PD-L1 class is a crowded one and Keytruda’s dominance hasn’t scared off new players from entering the field.

Keytruda adds another NSCLC approval in Europe

Keytruda adds another NSCLC approval in Europe Squamous NSCLC completes first-line dominance. The European Commission has granted MSD's Keytruda approval in another major lung cancer setting. ... With this approval, more patients with non-small cell lung cancer may have the opportunity to benefit

Celgene’s Abraxane fails pancreatic cancer trial

Celgene’s Abraxane fails pancreatic cancer trial Celgene picked up the first of these last October when Abraxane was cleared alongside Merck &Co/MSD’s Keytruda (pembrolizumab) for frontline metastatic squamous non-small cell lung cancer. ... for a breast cancer indication – and in September, the

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics